Jump to content

Peter Openshaw (immunologist)

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 04:23, 12 August 2024 (Open access bot: hdl updated in citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Peter Openshaw
Born (1954-11-11) 11 November 1954 (age 70)
Alma materGuy's Hospital
Scientific career
FieldsImmunology
InstitutionsImperial College London
ThesisBenefit and harm from immunity to respiratory syncytial virus (1988)

Peter John Morland Openshaw, CBE, FRCP, FMedSci (born 11 November 1954) is a British clinician and scientist specialising in lung immunology, particularly defence against viral infections. He trained in lung diseases and undertook a PhD in immunology before establishing a laboratory at St Mary's Hospital Medical School (later part of Imperial College London). He created the academic department of Respiratory Medicine and the Centre for Respiratory Infection at Imperial College and was elected President of the British Society for Immunology in 2014.

Early life

Openshaw was born in 1954 in Glastonbury, Somerset. He attended Millfield Junior School, then the Quaker boarding schools Sidcot School and Bootham School, followed by Guy's Hospital Medical School (University of London). He earned an intercalated BSc in Physiology (Hons., 1976), qualified in medicine (MB BS, 1979), and worked at the Royal Brompton Hospital and as medical registrar at Royal Postgraduate Medical School (Hammersmith Hospital).

Career

Immunological work

Originally trained in lung mechanics, his PhD at the National Institute for Medical Research at Mill Hill, London was in T cell immunology.[1] He has worked on protective and harmful immunological reactions to viruses, inflammatory lung disease and vaccine development since 1985, writing over 300 scientific articles (h-index= 101).[2] He was President of the British Society for Immunology between 2013 and 2018, the first clinician to hold the role. Openshaw was a member of the Academy of Medical Sciences and British Society for Immunology expert taskforce on COVID-19.[3]

Respiratory virus research

He was awarded the Chanock prize (2012, Santa Fe USA) in recognition of his lifetime achievement in work on respiratory syncytial virus (RSV) research. He has been involved in influenza policy since 2002 as a member of UK advisory boards and was Vice President of European Scientific Working Group on Influenza (ESWI) from 2009-2014. In 2009 he set up the MOSAIC consortium, a collaboration of 45 co-investigators studying the host response to influenza in patients admitted to 11 hospitals in London and Liverpool (Wellcome Trust/MRC support) and directs studies of viral challenge of human volunteers.

He was Theme Lead for the Respiratory Theme and later the Infection Theme of the NIHR Imperial Biomedical Research Centre. Currently he works as Head of the Respiratory Infections Section at the National Heart and Lung Institute, a department of Imperial College London.[3]

Academic leadership

Openshaw established the academic department of Respiratory Medicine on the St Mary’s Campus of Imperial College and created the Centre for Respiratory Infection (Wellcome Trust funded). He has sat on numerous governmental, grant awarding and international committees.

He was elected an Imperial College Consul for the Faculty of Medicine in 2016, becoming Senior Consul in 2019[4] and then Proconsul.[5] He co-chaired Imperial's Working Together Task Group in 2021.[6]

Advisory

Openshaw is a member of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) in the UK.[7]

Honours

Openshaw is a Fellow of the Royal College of Physicians (1994), a Fellow of the Academy of Medical Sciences (1999) and a Fellow of the Society of Biology (2014).[8] He was selected as Senior Investigator by National Institute for Health Research (NIHR) in 2013 and 2020.[9][10]

Openshaw was appointed Commander of the Order of the British Empire (CBE) in the 2022 New Year Honours for services to medicine and immunology.[11]

Selected publications

References

  1. ^ "Future Virology Editorial Board". Future Virology. Retrieved 10 March 2024.
  2. ^ "Peter Openshaw". scholar.google.com. Retrieved 10 March 2024.
  3. ^ a b "Peter Openshaw". www.imperial.ac.uk. Retrieved 10 March 2024.
  4. ^ "Professor Peter Openshaw elected as Senior Consul at Imperial". Imperial News. 30 May 2019. Retrieved 11 March 2024.
  5. ^ "Knighthoods for Chief Medical Officers in COVID Dominated New Year Honours". Medscape UK. Retrieved 11 March 2024.
  6. ^ "Working Together Task Group". Imperial College London. Retrieved 11 March 2024.
  7. ^ "New and Emerging Respiratory Virus Threats Advisory Group". GOV.UK. Retrieved 20 March 2020.
  8. ^ "Honours and Memberships - Peter Openshaw - Professor of Experimental Medicine". www.imperial.ac.uk. Retrieved 11 March 2024.
  9. ^ Openshaw, Peter (4 October 2017). "Vaccines are vital: there's never been a more exciting time to be a vaccinologist!". Imperial Medicine Blog. Retrieved 11 March 2024.
  10. ^ "NIHR Senior Investigator awards for Imperial". NIHR Imperial Biomedical Research Centre. Retrieved 11 March 2024.
  11. ^ "No. 63571". The London Gazette (Supplement). 1 January 2022. p. N10.